Topos Bio
Topos Bio is an AI-native drug discovery company building all-atom foundation models for intrinsically disordered proteins (IDPs) — dynamic, flexible proteins implicated in diseases such as Alzheimer's and prostate cancer. Its Topos-1 foundation model generates physically realistic conformational ensembles for flexible proteins, aiming to make previously undruggable targets therapeutically viable. The company is backed by Threshold Ventures. No public API or developer platform is currently published.
Topos Bio is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Drug Discovery, Artificial Intelligence, and Biotech.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
Other 1
Properties that don't map to a standard resource type